Literature DB >> 29780923

Possible dissemination of conjunctival melanoma along tear flow path.

Toshinobu Kubota1, Tomonori Kawasaki2.   

Abstract

Entities:  

Keywords:  Conjunctiva; Dissemination; Melanoma; Tear flow

Year:  2018        PMID: 29780923      PMCID: PMC5956803          DOI: 10.1016/j.ajoc.2018.02.017

Source DB:  PubMed          Journal:  Am J Ophthalmol Case Rep        ISSN: 2451-9936


× No keyword cloud information.

Case report

A 60-year-old woman presented with conjunctival melanoma arising from pigmented primary acquired melanosis (PAM) located in the temporal upper bulbar conjunctiva of her right eye. The tumor had a diameter of 16 mm and height of 11 mm (Fig. 1A and Fig. 2A). Magnetic resonance imaging did not reveal tumor growth in the lacrimal sac (Fig. 2B) and pigmented PAM was not detected in other areas of the conjunctiva. Complete tumor resection was performed using the no-touch technique. At 34 months after the initial visit, conjunctival melanoma dissemination was observed in the lower bulbar conjunctiva (Fig. 1B), and was resected in the same manner. At 66 months after the initial visit, melanoma involvement was observed in the lacrimal sac (Fig. 1C and Fig. 2C), and was treated using proton beam radiotherapy. Histological examination of the lesions from the conjunctiva lacrimal sac revealed that both showed the same cytological and immunohistochemical features (Fig. 3).
Fig. 1

Conjunctival melanoma was detected at the upper temporal forniceal conjunctiva at the patient's initial visit (A), at the lower temporal epibulbar conjunctiva approximately 3 years after the initial visit (B), and in the lacrimal sac approximately 5 years after the initial visit (C).

Fig. 2

Magnetic resonance images at the patient's initial visit, showing a mass lesion at the upper temporal forniceal conjunctiva (A), but no visible lesion in the lacrimal sac (B). Computed tomography image showing a mass lesion in the lacrimal sac at approximately 5 years after the initial visit (C).

Fig. 3

Histological examination revealing that the tumor cells comprise epithelioid and plump spindle cells (A, hematoxylin-eosin staining; original magnification, 200 × ). Immunostaining reveals that tumor cells are positive for HMB-45 (B) and S100 (C). Original magnification 400 × .

Conjunctival melanoma was detected at the upper temporal forniceal conjunctiva at the patient's initial visit (A), at the lower temporal epibulbar conjunctiva approximately 3 years after the initial visit (B), and in the lacrimal sac approximately 5 years after the initial visit (C). Magnetic resonance images at the patient's initial visit, showing a mass lesion at the upper temporal forniceal conjunctiva (A), but no visible lesion in the lacrimal sac (B). Computed tomography image showing a mass lesion in the lacrimal sac at approximately 5 years after the initial visit (C). Histological examination revealing that the tumor cells comprise epithelioid and plump spindle cells (A, hematoxylin-eosin staining; original magnification, 200 × ). Immunostaining reveals that tumor cells are positive for HMB-45 (B) and S100 (C). Original magnification 400 × .

Discussion

Conjunctival melanomas occasionally exhibit recurrences in the lacrimal drainage. However, typically several conjunctival recurrences occur first, and nasolacrimal recurrences appear at a median of five or six years after initial treatments,, along with recurrences at the nasal passage terminus. Most cancers have hematogenous and lymphatic dissemination patterns, and the lacrimal sac melanoma may have developed within the PAM. However, melanoma cells have been detected in tears in patients with conjunctival melanoma, and thus it is possible that conjunctival melanoma may have another dissemination pattern along tear flow path.

Conclusion

Ophthalmologists should be aware that conjunctival melanoma may have a dissemination pattern along the tear flow path.

Author conflicts of interest

None.

Authorship

All authors attest that they meet the current ICMJE Criteria for Authorship.

Funding

None.

Patient consent

Written consent to publish was obtained from the patient.
  5 in total

1.  Tear cytology in conjunctival melanoma.

Authors:  J S Weiss; P Perusse; F Reale
Journal:  Am J Ophthalmol       Date:  1991-05-15       Impact factor: 5.258

Review 2.  Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture.

Authors:  J A Shields; C L Shields; P De Potter
Journal:  Arch Ophthalmol       Date:  1997-06

3.  Epistaxis or epiphora as a sign for extension of a conjunctival melanoma. A series of six patients with nasolacrimal recurrence.

Authors:  G S Missotten; J Gambrelle; D de Wolff-Rouendaal; R J W de Keizer
Journal:  Br J Ophthalmol       Date:  2010-06-27       Impact factor: 4.638

4.  Malignant melanomas of the conjunctiva, nasal cavity, and paranasal sinuses.

Authors:  D M Robertson; J L Hungerford; A McCartney
Journal:  Am J Ophthalmol       Date:  1989-10-15       Impact factor: 5.258

5.  Nasal and orbital recurrence of conjunctival melanoma 21 years after exenteration.

Authors:  A D Paridaens; A C McCartney; R J Lavelle; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.